Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Pfenex stock
Own Pfenex stock in just a few minutes.
Pfenex Inc is a biotechnology business based in the US. Pfenex shares (PFNX) are listed on the NYSE MKT and all prices are listed in US Dollars. Pfenex employs 88 staff and has a trailing 12-month revenue of around USD$41.1 million.
How to buy shares in Pfenex
- Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
- Search for Pfenex. Find the stock by name or ticker symbol: PFNX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Pfenex reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Pfenex, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Pfenex. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
Pfenex share price
Use our graph to track the performance of PFNX stocks over time.Pfenex shares at a glance
Information last updated 2020-11-01.
| 52-week range | USD$5.26 - USD$12.94 |
|---|---|
| 50-day moving average | USD$12.7293 |
| 200-day moving average | USD$9.0912 |
| Wall St. target price | USD$13 |
| PE ratio | 268.6667 |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | USD$0.03 |
Buy Pfenex shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Pfenex stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Is Pfenex under- or over-valued?
Valuing Pfenex stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Pfenex's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Pfenex's P/E ratio
Pfenex's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 269x. In other words, Pfenex shares trade at around 269x recent earnings.
Pfenex's EBITDA
Pfenex's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$2.6 million.
The EBITDA is a measure of a Pfenex's overall financial performance and is widely used to measure a its profitability.
Pfenex financials
| Revenue TTM | USD$41.1 million |
|---|---|
| Gross profit TTM | USD$45.4 million |
| Return on assets TTM | -4.95% |
| Return on equity TTM | 0% |
| Profit margin | -14.1% |
| Book value | $2.155 |
| Market capitalisation | USD$437.3 million |
TTM: trailing 12 months
Shorting Pfenex shares
There are currently 539,032 Pfenex shares held short by investors – that's known as Pfenex's "short interest". This figure is 31.3% down from 785,072 last month.
There are a few different ways that this level of interest in shorting Pfenex shares can be evaluated.
Pfenex's "short interest ratio" (SIR)
Pfenex's "short interest ratio" (SIR) is the quantity of Pfenex shares currently shorted divided by the average quantity of Pfenex shares traded daily (recently around 579604.30107527). Pfenex's SIR currently stands at 0.93. In other words for every 100,000 Pfenex shares traded daily on the market, roughly 930 shares are currently held short.
However Pfenex's short interest can also be evaluated against the total number of Pfenex shares, or, against the total number of tradable Pfenex shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Pfenex's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Pfenex shares in existence, roughly 20 shares are currently held short) or 0.0184% of the tradable shares (for every 100,000 tradable Pfenex shares, roughly 18 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Pfenex.
Find out more about how you can short Pfenex stock.
Pfenex share dividends
We're not expecting Pfenex to pay a dividend over the next 12 months.
Pfenex share price volatility
Over the last 12 months, Pfenex's shares have ranged in value from as little as $5.26 up to $12.94. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE MKT average) beta is 1, while Pfenex's is 1.3233. This would suggest that Pfenex's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Pfenex overview
Pfenex Inc., a clinical-stage development and licensing biotechnology company, focuses on developing protein therapies for unmet patient needs. Its lead product candidate include PF708, a therapeutic equivalent drug candidate to Forteo (teriparatide) for the treatment of osteoporosis. The company also develops PF743, a recombinant crisantaspase; PF745, a recombinant crisantaspase with half-life extension technology; and PF810, a peptide based next generation therapeutic which is in preclinical development, as well as offers sparX-1 (PF753) and sparX-2 (PF754). In addition, it has license and supply agreements for CRM197, a non-toxic mutant of diphtheria toxin. Pfenex Inc. is headquartered in San Diego, California. As of September 29, 2020, Pfenex Inc. operates as a subsidiary of Ligand Pharmaceuticals Incorporated.
Frequently asked questions
More guides on Finder
-
How to buy Sigma Labs stock
Steps to owning and managing SGLB, with 24-hour and historical pricing before you buy.
-
How to buy Simpson Manufacturing CoInc stock
Steps to owning and managing SSD, with 24-hour and historical pricing before you buy.
-
How to buy Sequans Communications S-A stock
Steps to owning and managing SQNS, with 24-hour and historical pricing before you buy.
-
How to buy SFL Corporation stock
Steps to owning and managing SFL, with 24-hour and historical pricing before you buy.
-
How to buy Senmiao Technology stock
Steps to owning and managing AIHS, with 24-hour and historical pricing before you buy.
-
How to buy Sensata Technologies Holding stock
Steps to owning and managing ST, with 24-hour and historical pricing before you buy.
-
How to buy Select Bancorp stock
Steps to owning and managing SLCT, with 24-hour and historical pricing before you buy.
-
How to buy Second Sight Medical Products stock
Steps to owning and managing EYES, with 24-hour and historical pricing before you buy.
-
How to buy Sibanye Stillwater stock
Steps to owning and managing SBSW, with 24-hour and historical pricing before you buy.
-
How to buy Shinhan Financial Group CoLtd stock
Steps to owning and managing SHG, with 24-hour and historical pricing before you buy.
Ask an Expert